US drags 3QFY22 earnings; inspections key to a revival
TRP's 3QFY22 performance missed our estimate. The US Generics business remains the major drag on overall performance, with a lack of new...
273 Views
Torrent Pharmaceuticals: Branded Business Solid but Generics Stumble
Incorporated in 1959, Torrent has a strong presence in domestic and semi-regulated markets and a growing presence in regulated markets.
160 Views
Torrent Pharma (Results Review Q2FY22): Tepid quarter; steady outlook. Maintain ADD
The company repaid debt of INR4.9bn in H1 and is on track to reduce it by ~INR10bn in FY22. We reduce our EBITDA estimates by 4-5% for FY22-23e and...
71 Views
Torrent Pharmaceuticals: India Growth Drives Steady Numbers
A strong growth track in top brands, measured new launches (including innovative launches) besides strong balance sheet and comfort on corporate...
108 Views
HSIE Results Daily: DLF, Dr. Reddy’s, IndusInd Bank and More
HSIE Results Daily DLF: DLF surprised positively on presales at INR 10bn (6.6x/-5% YoY/QoQ) despite the lockdown during the quarter. While office...
96 Views